Impact of High Protein Intake on Preterm Infants
Published On: 06 Mar, 2025 2:37 PM | Updated On: 09 Mar, 2025 7:30 AM

Impact of High Protein Intake on Preterm Infants

Sufficient protein intake is essential for the growth and development of preterm infants. This study examined the impacts of high protein (HP) versus low protein (LP) diets on neurodevelopment, growth, and biochemical issues in these children.

We conducted a systematic search for randomized and quasi-randomized trials involving protein supplementation in preterm infants (born before 37 weeks of gestation) in accordance with PRISMA guidelines, utilizing three databases and four registers. A random-effects model was employed to evaluate the effects of HP (≥3.5 g/kg/d) compared to LP (<3.5 g/kg/d).

The study revealed the following:

Analysis of 44 studies indicated that HP intake may slightly lower the likelihood of survival without neurodisability by 12 months, with low certainty evidence. 

Additionally, HP might increase the risk of cognitive impairment at toddler age (two studies, 436 children; RR 1.36 [0.89, 2.09]), also with low certainty evidence. 

At discharge or 36 weeks, HP intake was associated with higher weight and head circumference z-scores.

However, HP likely raised the risk of conditions such as hypophosphatemia, hypercalcemia, refeeding syndrome, and elevated blood urea, while reducing the risk of hyperglycemia.

To summarize, a HP diet for preterm infants may negatively affect neonatal metabolism and contribute to future neurodisability, exhibiting limited short-term benefits for growth.

Impact statement

  • Recommending high protein intake after birth for preterm infants may be detrimental to their survival, neurological health, and metabolism during infancy, with no significant growth benefits beyond the neonatal phase.
  • Protein intake of ≥3.5 g/kg/d is not advisable for preterm infants. 

Source: Das, S., McClintock, T., Cormack, B.E. et al. High protein intake on later outcomes in preterm children: a systematic review and meta-analysis. Pediatr Res 97, 67–80 (2025). https://doi.org/10.1038/s41390-024-03296-z

user
IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks